While the pharma industry sorts out what impact a Biden administration is likely to have on drug pricing, another consideration meaningful for the sector is the trade relations between China and the U.S. — and how they may affect drug patent law.  As part of recent trade negotiations, Chinese authorities agreed to change their intellectual property…